Tsukasa Ishihara

YM‐53601, a novel squalene synthase inhibitor, reduces plasma cholesterol and triglyceride levels in several animal species

Tohru Ugawa, Hirotoshi Kakuta, Hirosh Moritani et al. · British Journal of Pharmacology · 2000 · 78 citations · Full text

Cardiac Arrhythmias and Left Ventricular Hypertrophy in Dipper and Nondipper Patients With Essential Hypertension

Hiroshi Ijiri, Isao Kohno, Dongfeng Yin et al. · Japanese Circulation Journal · 2000 · 46 citations · Full text

Regional myocardial sympathetic dysinnervation in patients with coronary vasospasm

Hajime Takano, Takamichi Nakamura, Takeshi Satou et al. · The American Journal of Cardiology · 1995 · 42 citations

Cardiogenic Shock, Cardiovascular Disease, Physiology +5

Discovery of <i>N</i> -[2-Hydroxy-6-(4-methoxybenzamido)phenyl]-4- (4-methyl-1,4-diazepan-1-yl)benzamide (Darexaban, YM150) as a Potent and Orally Available Factor Xa Inhibitor

Fukushi Hirayama, Hiroyuki Koshio, Tsukasa Ishihara et al. · Journal of Medicinal Chemistry · 2011 · 35 citations · Full text

Administration-Time-Dependent Effects of Diltiazem on the 24-Hour Blood Pressure Profile of Essential Hypertension Patients

Isao Kohno, Hiroshi Iwasaki, M Okutani et al. · Chronobiology International · 1997 · 34 citations